Biomedical measurand type.
1PWV was also correlated with age, systolic blood pressure, and C-reactive protein.
2Reducing systolic blood pressure is standard of care for secondary stroke prevention.
3In pre-approval studies, ProAmatine increased standing systolic blood pressure for one minute.
4The latter association remained significant after adjustment for systolic blood pressure and age.
5Conclusion: Liraglutide had greater hypoglycemic, weight-reducing and systolic blood pressure-lowering effects than placebo.
6Elevated systolic blood pressure accounted for the majority of inadequate control.
7Stented patients were younger, had higher systolic blood pressure and more severe ARAS.
8Remission was significantly associated with captopril therapy and control of systolic blood pressure.
9Age and systolic blood pressure correlated with plaque extents in both the aortas.
10This mainly reflected a decrease in the systolic blood pressure in the elderly.
11Decaffeinated coffee intake was not associated with mean systolic blood pressure.
12Standing systolic blood pressure was significantly lower in the isradipine group.
13Drivers for decreased risk were improvements in blood cholesterol and systolic blood pressure.
14We also examined the association between postdonation systolic blood pressure and graft failure.
15During treatments systolic blood pressure was significantly increased in conscious rats.
16Among patients with DM, increasing age and systolic blood pressure were associated with CKD.
Translations for systolic blood pressure